These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24767768)

  • 1. Respiratory microbiome in IPF: cause, effect, or biomarker?
    Molyneaux PL; Maher TM
    Lancet Respir Med; 2014 Jul; 2(7):511-3. PubMed ID: 24767768
    [No Abstract]   [Full Text] [Related]  

  • 2. The changing landscape of idiopathic pulmonary fibrosis.
    The Lancet Respiratory Medicine
    Lancet Respir Med; 2014 Jul; 2(7):507. PubMed ID: 25008951
    [No Abstract]   [Full Text] [Related]  

  • 3. Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study.
    Han MK; Zhou Y; Murray S; Tayob N; Noth I; Lama VN; Moore BB; White ES; Flaherty KR; Huffnagle GB; Martinez FJ;
    Lancet Respir Med; 2014 Jul; 2(7):548-56. PubMed ID: 24767767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Lung Microbiome in Idiopathic Pulmonary Fibrosis: A Promising Approach for Targeted Therapies.
    Fastrès A; Felice F; Roels E; Moermans C; Corhay JL; Bureau F; Louis R; Clercx C; Guiot J
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis.
    Invernizzi R; Wu BG; Barnett J; Ghai P; Kingston S; Hewitt RJ; Feary J; Li Y; Chua F; Wu Z; Wells AU; George PM; Renzoni EA; Nicholson AG; Rice A; Devaraj A; Segal LN; Byrne AJ; Maher TM; Lloyd CM; Molyneaux PL
    Am J Respir Crit Care Med; 2021 Feb; 203(3):339-347. PubMed ID: 32692582
    [No Abstract]   [Full Text] [Related]  

  • 6. Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients.
    Tong X; Su F; Xu X; Xu H; Yang T; Xu Q; Dai H; Huang K; Zou L; Zhang W; Pei S; Xiao F; Li Y; Wang C
    Front Cell Infect Microbiol; 2019; 9():149. PubMed ID: 31165050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiome in lung explants of idiopathic pulmonary fibrosis: a case-control study in patients with end-stage fibrosis.
    Kitsios GD; Rojas M; Kass DJ; Fitch A; Sembrat JC; Qin S; Veraldi KL; Gibson KF; Lindell K; Pilewski JM; Methe B; Li K; McDyer J; McVerry BJ; Morris A
    Thorax; 2018 May; 73(5):481-484. PubMed ID: 28802277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis.
    Molyneaux PL; Cox MJ; Wells AU; Kim HC; Ji W; Cookson WO; Moffatt MF; Kim DS; Maher TM
    Respir Res; 2017 Feb; 18(1):29. PubMed ID: 28143484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis.
    Invernizzi R; Molyneaux PL
    Eur Respir Rev; 2019 Jun; 28(152):. PubMed ID: 31285290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the lung microbiome as a therapeutic target in the management of idiopathic pulmonary fibrosis: role of antioxidant/antibiotic combination therapy.
    Varone F; Gibiino G; Gasbarrini A; Richeldi L
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6379-6386. PubMed ID: 31364146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the Role of Bioactive Food Ingredients and the Microbiome in Idiopathic Pulmonary Fibrosis.
    Mercader-Barceló J; Truyols-Vives J; Río C; López-Safont N; Sala-Llinàs E; Chaplin A
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis.
    Huang Y; Ma SF; Espindola MS; Vij R; Oldham JM; Huffnagle GB; Erb-Downward JR; Flaherty KR; Moore BB; White ES; Zhou T; Li J; Lussier YA; Han MK; Kaminski N; Garcia JGN; Hogaboam CM; Martinez FJ; Noth I;
    Am J Respir Crit Care Med; 2017 Jul; 196(2):208-219. PubMed ID: 28157391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The microbiome in IPF: tissue is not the issue.
    Molyneaux PL
    Thorax; 2021 Mar; 76(3):218. PubMed ID: 33593961
    [No Abstract]   [Full Text] [Related]  

  • 14. The lung microbiome in idiopathic pulmonary fibrosis. What does it mean and what should we do about it?
    Morris A; Gibson K; Collman RG
    Am J Respir Crit Care Med; 2014 Oct; 190(8):850-2. PubMed ID: 25317462
    [No Abstract]   [Full Text] [Related]  

  • 15. Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases.
    Amati F; Stainer A; Mantero M; Gramegna A; Simonetta E; Suigo G; Voza A; Nambiar AM; Cariboni U; Oldham J; Molyneaux PL; Spagnolo P; Blasi F; Aliberti S
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Danger-associated molecular patterns and danger signals in idiopathic pulmonary fibrosis.
    Ellson CD; Dunmore R; Hogaboam CM; Sleeman MA; Murray LA
    Am J Respir Cell Mol Biol; 2014 Aug; 51(2):163-8. PubMed ID: 24749648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiographic Honeycombing and Altered Lung Microbiota in Patients with Idiopathic Pulmonary Fibrosis.
    Dickson RP; Huffnagle GB; Flaherty KR; White ES; Martinez FJ; Erb-Downward JR; Moore BB; O'Dwyer DN
    Am J Respir Crit Care Med; 2019 Dec; 200(12):1544-1547. PubMed ID: 31419390
    [No Abstract]   [Full Text] [Related]  

  • 18. Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis.
    Oda K; Yatera K; Fujino Y; Kido T; Hanaka T; Sennari K; Fushimi K; Matsuda S; Mukae H
    Respir Investig; 2018 Jan; 56(1):64-71. PubMed ID: 29325684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for Helicobacter pylori in Idiopathic Pulmonary Fibrosis Lung Biopsies.
    Kreuter M; Kirsten D; Bahmer T; Penzel R; Claussen M; Ehlers-Tenenbaum S; Muley T; Palmowski K; Eichinger M; Leider M; Herth FJ; Rabe KF; Bittmann I; Warth A
    Respiration; 2016; 91(1):3-8. PubMed ID: 26645213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiome in interstitial lung disease: from pathogenesis to treatment target.
    Salisbury ML; Han MK; Dickson RP; Molyneaux PL
    Curr Opin Pulm Med; 2017 Sep; 23(5):404-410. PubMed ID: 28650861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.